journal
https://read.qxmd.com/read/38628810/aav-based-gene-replacement-the-promise-of-gene-therapy-for-deafness
#1
Jieyu Qi, Liyan Zhang, Renjie Chai
No abstract text is available yet for this article.
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38617976/enigmatic-exosomal-connection-in-lung-cancer-drug-resistance
#2
REVIEW
Sambit K Patra, Rajeev K Sahoo, Stuti Biswal, Shikshya S Panda, Bijesh Kumar Biswal
Lung cancer remains a significant global health concern with limited treatment options and poor prognosis, particularly in advanced stages. Small extracellular vesicles such as exosomes, secreted by cancer cells, play a pivotal role in mediating drug resistance in lung cancer. Exosomes have been found to facilitate intercellular communication by transferring various biomolecules between cancer cells and their microenvironment. Additionally, exosomes can transport signaling molecules promoting cancer cell survival and proliferation conferring resistance to chemotherapy...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38617975/a-new-immune-based-prognostic-scoring-system-for-multiple-myeloma
#3
Mohamed Hammad, Hossam M Ashour
No abstract text is available yet for this article.
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38617974/optimized-allele-specific-silencing-of-the-dominant-negative-col6a1-g293r-substitution-causing-collagen-vi-related-dystrophy
#4
JOURNAL ARTICLE
Astrid Brull, Apurva Sarathy, Véronique Bolduc, Grace S Chen, Riley M McCarty, Carsten G Bönnemann
Collagen VI-related dystrophies (COL6-RDs) are a group of severe, congenital-onset muscular dystrophies for which there is no effective causative treatment. Dominant-negative mutations are common in COL6A1 , COL6A2 , and COL6A 3 genes, encoding the collagen α1, α2, and α3 (VI) chains. They act by incorporating into the hierarchical assembly of the three α (VI) chains and consequently produce a dysfunctional collagen VI extracellular matrix, while haploinsufficiency for any of the COL6 genes is not associated with disease...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38617973/control-of-endothelial-cell-function-and-arteriogenesis-by-meg3-ezh2-epigenetic-regulation-of-integrin-expression
#5
JOURNAL ARTICLE
Hywel Dunn-Davies, Tatiana Dudnakova, Antonella Nogara, Julie Rodor, Anita C Thomas, Elisa Parish, Philippe Gautier, Alison Meynert, Igor Ulitsky, Paolo Madeddu, Andrea Caporali, Andrew Baker, David Tollervey, Tijana Mitić
Epigenetic processes involving long non-coding RNAs regulate endothelial gene expression. However, the underlying regulatory mechanisms causing endothelial dysfunction remain to be elucidated. Enhancer of zeste homolog 2 (EZH2) is an important rheostat of histone H3K27 trimethylation (H3K27me3) that represses endothelial targets, but EZH2 RNA binding capacity and EZH2:RNA functional interactions have not been explored in post-ischemic angiogenesis. We used formaldehyde/UV-assisted crosslinking ligation and sequencing of hybrids and identified a new role for maternally expressed gene 3 (MEG3)...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38606144/identification-of-film-based-formulations-that-move-mrna-lipid-nanoparticles-out-of-the-freezer
#6
JOURNAL ARTICLE
Trang Nguyen Kieu Doan, Madison M Davis, Maria A Croyle
COVID-19 vaccines consisting of mRNA lipid nanoparticles (LNPs) encoding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antigen protected millions of people from severe disease; however, they must be stored frozen prior to use. The objective of this study was to evaluate the compatibility and stability of mRNA LNPs within a polymer-based film matrix. An optimized formulation of polymer base, glycerol, surfactants, and PEGylated lipid that prevents damage to the LNP due to physical changes during the film-forming process (osmotic stress, surface tension, spatial stress, and water loss) was identified...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38590918/erratum-favorable-efficacy-and-reduced-acute-neurotoxicity-by-antisense-oligonucleotides-with-2-4-bna-lna-with-9-aminoethoxy-phenoxazine
#7
Taiki Matsubayashi, Kotaro Yoshioka, Su Su Lei Mon, Maho Katsuyama, Chunyan Jia, Takao Yamaguchi, Rintaro Iwata Hara, Tetsuya Nagata, Osamu Nakagawa, Satoshi Obika, Takanori Yokota
[This corrects the article DOI: 10.1016/j.omtn.2024.102161.].
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38584818/inhibition-of-mir-25-ameliorates-cardiac-and-skeletal-muscle-dysfunction-in-aged-mdx-utrn-haploinsufficient-mice
#8
JOURNAL ARTICLE
Sacha V Kepreotis, Jae Gyun Oh, Mina Park, Jimeen Yoo, Cholong Lee, Mark Mercola, Roger J Hajjar, Dongtak Jeong
Dystrophic cardiomyopathy is a significant feature of Duchenne muscular dystrophy (DMD). Increased cardiomyocyte cytosolic calcium (Ca2+ ) and interstitial fibrosis are major pathophysiological hallmarks that ultimately result in cardiac dysfunction. MicroRNA-25 (miR-25) has been identified as a suppressor of both sarcoplasmic reticulum calcium ATPase 2a (SERCA2a) and mothers against decapentaplegic homolog-7 (Smad7) proteins. In this study, we created a gene transfer using an miR-25 tough decoy (TuD) RNA inhibitor delivered via recombinant adeno-associated virus serotype 9 (AAV9) to evaluate the effect of miR-25 inhibition on cardiac and skeletal muscle function in aged dystrophin/utrophin haploinsufficient mice mdx/utrn ( +/- ), a validated transgenic murine model of DMD...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38576454/physiologically-based-modeling-of-lnp-mediated-delivery-of-mrna-in-the-vascular-system
#9
JOURNAL ARTICLE
Hamideh Parhiz, Vladimir V Shuvaev, Qin Li, Tyler E Papp, Awurama A Akyianu, Ruiqi Shi, Amir Yadegari, Hamna Shahnawaz, Sean C Semple, Barbara L Mui, Drew Weissman, Vladimir R Muzykantov, Patrick M Glassman
RNA therapeutics are an emerging, powerful class of drugs with potential applications in a wide range of disorders. A central challenge in their development is the lack of clear pharmacokinetic (PK)-pharmacodynamic relationship, in part due to the significant delay between the kinetics of RNA delivery and the onset of pharmacologic response. To bridge this gap, we have developed a physiologically based PK/pharmacodynamic model for systemically administered mRNA-containing lipid nanoparticles (LNPs) in mice...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38571746/correction-of-human-nonsense-mutation-via-adenine-base-editing-for-duchenne-muscular-dystrophy-treatment-in-mouse
#10
JOURNAL ARTICLE
Ming Jin, Jiajia Lin, Haisen Li, Zhifang Li, Dong Yang, Yin Wang, Yuyang Yu, Zhurui Shao, Long Chen, Zhiqiang Wang, Yu Zhang, Xiumei Zhang, Ning Wang, Chunlong Xu, Hui Yang, Wan-Jin Chen, Guoling Li
Duchenne muscular dystrophy (DMD) is the most prevalent herediatry disease in men, characterized by dystrophin deficiency, progressive muscle wasting, cardiac insufficiency, and premature mortality, with no effective therapeutic options. Here, we investigated whether adenine base editing can correct pathological nonsense point mutations leading to premature stop codons in the dystrophin gene. We identified 27 causative nonsense mutations in our DMD patient cohort. Treatment with adenine base editor (ABE) could restore dystrophin expression by direct A-to-G editing of pathological nonsense mutations in cardiomyocytes generated from DMD patient-derived induced pluripotent stem cells...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38560422/secondary-follicles-enable-efficient-germline-mtdna-base-editing-at-hard-to-edit-site
#11
JOURNAL ARTICLE
Qin Xie, Haibo Wu, Hui Long, Caiwen Xiao, Jiaxin Qiu, Weina Yu, Xueyi Jiang, Junbo Liu, Shuo Zhang, Qifeng Lyu, Lun Suo, Yanping Kuang
Efficient germline mtDNA editing is required to construct disease-related animal models and future gene therapy. Recently, the DddA-derived cytosine base editors (DdCBEs) have made mitochondrial genome (mtDNA) precise editing possible. However, there still exist challenges for editing some mtDNA sites in germline via zygote injection, probably due to the suspended mtDNA replication during preimplantation development. Here, we introduce a germline mtDNA base editing strategy: injecting DdCBEs into oocytes of secondary follicles, at which stage mtDNA replicates actively...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38549914/tgf-%C3%AE-1-triggered-bmi1-and-smad2-cooperatively-regulate-mir-191-to-modulate-bone-formation
#12
JOURNAL ARTICLE
Xiao-Fei Zhang, Zi-Xuan Wang, Bo-Wen Zhang, Kun-Peng Huang, Tian-Xing Ren, Ting Wang, Xing Cheng, Ping Hu, Wei-Hua Xu, Jin Li, Jin-Xiang Zhang, Hui Wang
Transforming growth factor β 1 (TGF-β1), as the most abundant signaling molecule in bone matrix, is essential for bone homeostasis. However, the signaling transduction of TGF-β1 in the bone-forming microenvironment remains unknown. Here, we showed that microRNA-191 (miR-191) was downregulated during osteogenesis and further decreased by osteo-favoring TGF-β1 in bone marrow mesenchymal stem cells (BMSCs). MiR-191 was lower in bone tissues from children than in those from middle-aged individuals and it was negatively correlated with collagen type I alpha 1 chain ( COL1A1 )...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38549913/the-mrnacalc-webserver-accounts-for-the-n1-methylpseudouridine-hypochromicity-to-enable-precise-nucleoside-modified-mrna-quantification
#13
JOURNAL ARTICLE
Esteban Finol, Sarah E Krul, Sean J Hoehn, Xudong Lyu, Carlos E Crespo-Hernández
Nucleoside-modified messenger RNA (mRNA) technologies necessarily incorporate N1-methylpseudouridine into the mRNA molecules to prevent the over-stimulation of cytoplasmic RNA sensors. Despite this modification, mRNA concentrations remain mostly determined through the measurement of UV absorbance at 260 nm wavelength (A260 ). Herein, we report that the N1-methylpseudouridine absorbs approximately 40% less UV light at 260 nm than uridine, and its incorporation into mRNAs leads to the under-estimation of nucleoside-modified mRNA concentrations, with 5%-15% error, in an mRNA-sequence-dependent manner...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38545620/anti-mir-141-3p-maintains-homeostasis-between-autophagy-and-apoptosis-by-targeting-yy1-in-the-fetal-lumbosacral-defecation-center-of-rats
#14
JOURNAL ARTICLE
Yue Li, Peiqi Liu, Yifan Yao, Weilin Wang, Huimin Jia, Yuzuo Bai, Zhengwei Yuan, Zhonghua Yang
Anorectal malformations (ARMs) are congenital diseases that lead to postoperative fecal incontinence, constipation, and soiling, despite improvements in surgery; however, their pathological mechanisms remain unclear. Here, we report the role of microRNA-141-3p in maintaining homeostasis between apoptosis and autophagy in the lumbosacral defecation center of fetal rats with ARMs. Elevated microRNA-141-3p expression inhibited YIN-YANG-1 expression by binding its 3' UTR, and repressed autophagy and triggered apoptosis simultaneously...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38545619/-trans-amplifying-rna-expressing-functional-mirna-mediates-target-gene-suppression-and-simultaneous-transgene-expression
#15
JOURNAL ARTICLE
Ayşegül Yıldız, Aida Hasani, Tina Hempel, Nina Köhl, Aline Beicht, René Becker, Stefanie Hubich-Rau, Martin Suchan, Marco A Poleganov, Ugur Sahin, Tim Beissert
The co-delivery of microRNAs (miRNAs) and protein-coding RNA presents an opportunity for a combined approach to gene expression and gene regulation for therapeutic applications. Protein delivery is established using long mRNA, self-, and trans -amplifying RNA (taRNA), whereas miRNA delivery typically uses short synthetic oligonucleotides rather than incorporating it as a precursor into long RNA. Although miRNA delivery into the cell cytoplasm using long genomes of RNA viruses has been described, concerns have remained regarding low processing efficiency...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38511173/stat6-targeting-antisense-oligonucleotides-against-solitary-fibrous-tumor
#16
JOURNAL ARTICLE
Yi Li, Jose L Mondaza-Hernandez, David S Moura, Alexey S Revenko, Angelica Tolentino, John T Nguyen, Nam Tran, Clark A Meyer, Jose Merino-Garcia, Rafael Ramos, Davide Di Lernia, Javier Martin-Broto, Heather N Hayenga, Leonidas Bleris
Solitary fibrous tumor (SFT) is a rare, non-hereditary soft tissue sarcoma thought to originate from fibroblastic mesenchymal stem cells. The etiology of SFT is thought to be due to an environmental intrachromosomal gene fusion between NGFI-A-binding protein 2 (NAB2) and signal transducer and activator protein 6 (STAT6) genes on chromosome 12, wherein the activation domain of STAT6 is fused with the DNA-binding domain of NAB2 resulting in the oncogenesis of SFT. All NAB2-STAT6 fusion variations discovered in SFTs contain the C-terminal of STAT6 transcript, and thus can serve as target site for antisense oligonucleotides (ASOs)-based therapies...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38511172/accessory-oligos-for-neuronal-delivery-of-therapeutic-sirnas-for-als
#17
John J Rossi
No abstract text is available yet for this article.
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38495845/modifying-mirs-for-effective-reprogramming-of-fibroblasts-to-cardiomyocytes
#18
JOURNAL ARTICLE
Xinghua Wang, Syeda S Baksh, Richard E Pratt, Victor J Dzau, Conrad P Hodgkinson
Reprogramming scar fibroblasts into cardiomyocytes has been proposed to reverse the damage associated with myocardial infarction. However, the limited improvement in cardiac function calls for enhanced strategies. We reported enhanced efficacy of our miR reprogramming cocktail miR combo (miR-1, miR-133a, miR-208a, and miR-499) via RNA-sensing receptor stimulation. We hypothesized that we could combine RNA-sensing receptor activation with fibroblast reprogramming by chemically modifying miR combo. To test the hypothesis, miR combo was modified to enhance interaction with the RNA-sensing receptor Rig1 via the addition of a 5'-triphosphate (5'ppp) group...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38495844/metabolism-pathway-based-subtyping-in-endometrial-cancer-an-integrated-study-by%C3%A2-multi-omics-analysis-and-machine-learning-algorithms
#19
JOURNAL ARTICLE
Xiaodie Liu, Wenhui Wang, Xiaolei Zhang, Jing Liang, Dingqing Feng, Yuebo Li, Ming Xue, Bin Ling
Endometrial cancer (EC), the second most common malignancy in the female reproductive system, has garnered increasing attention for its genomic heterogeneity, but understanding of its metabolic characteristics is still poor. We explored metabolic dysfunctions in EC through a comprehensive multi-omics analysis (RNA-seq datasets from The Cancer Genome Atlas [TCGA], Cancer Cell Line Encyclopedia [CCLE], and GEO datasets; the Clinical Proteomic Tumor Analysis Consortium [CPTAC] proteomics; CCLE metabolomics) to develop useful molecular targets for precision therapy...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38481936/immunostimulatory-short-non-coding-rnas-in-the-circulation-of-patients-with-tuberculosis-infection
#20
JOURNAL ARTICLE
Justin Gumas, Takuya Kawamura, Megumi Shigematsu, Yohei Kirino
Mycobacterium tuberculosis (Mtb) infection is among the world's deadliest infectious diseases. Developing effective treatments and biomarkers for tuberculosis requires a deeper understanding of its pathobiology and host responses. Here, we report a comprehensive characterization of circulating short non-coding RNAs (sncRNAs) in plasma samples from Mtb-infected patients. We achieved this by pre-treating plasma RNAs with T4 polynucleotide kinase to convert all RNA ends to those compatible with sncRNA sequencing...
March 12, 2024: Molecular Therapy. Nucleic Acids
journal
journal
44027
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.